Ensysce Biosciences Inc (ENSCW) stock news · rev $5.2M
Ensysce Biosciences Inc (ENSCW) common stock listed on US.
This ENSCW news page leads with what Ensysce Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for ENSCW yet. We will not pad this page with generic market recap.
Latest reported ENSCW revenue for 2024-12-31 was $5.2M. Net income was -$8.0M. Revenue was up 133.6% from 2023-12-31 to 2024-12-31.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ENSCW stock page; for the tape open the quote page.
Not investment advice.